PEG-MGF (PEGYLATED MGF)

RECONSTITUTION & PROTOCOL

📖 OVERVIEW

Pegylated mechano growth factor with extended half-life for enhanced muscle repair and regeneration. Activates satellite cells in response to mechanical strain. Faster recovery from muscle damage, increased local tissue repair, and potential for enhanced muscle growth when paired with resistance training.

Animal and in vitro studies show PEGylation extends circulating half-life while retaining MGF bioactivity for muscle repair. IGF-1 LR3, MGF. Avoid with other IGF-1 analogs.

🔬 Primary Research
🌍 International Research

⚠️ Note: PEGylation may reduce receptor-binding potency compared to non-PEG MGF. Limited human data.

💧 RECONSTITUTION

Reconstitute 2 mg vial with 2 mL bacteriostatic water

FINAL CONCENTRATION:

1.0 mg/mL
1 unit on a U-100 insulin syringe = ~10 mcg PEG-MGF

📊 DOSE CONVERSION

DOSE (PEG-MGF) U-100 SYRINGE
200 mcg 20 units
300 mcg 30 units
400 mcg 40 units

📅 GENERAL TITRATION PROTOCOL

WEEKS 1–2

200 mcg (20 units) • 2–3× per week, post-workout

WEEKS 3–4

300 mcg (30 units) • 2–3× per week, post-workout

WEEKS 5–6

400 mcg (40 units) • 2–3× per week, post-workout

WEEK 7+

400–500 mcg (40–50 units) • 2–3× per week, then break

♻️ CYCLING INFORMATION

Standard Protocol

Run 4–6 weeks on, dosing 2–3× per week post-workout, then take time off (equal to or longer than the on-period) before repeating.
PEGylation extends the half-life from minutes (native MGF) to days, enabling systemic subQ/IM dosing rather than frequent localized injections.

⚡ SYNERGY & CAUTION

✅ SYNERGISTIC

  • IGF-1 LR3
    MGF acts on satellite cell activation while IGF-1 promotes protein synthesis and hypertrophy, offering complementary muscle-growth mechanisms.
  • Resistance training
    MGF is naturally upregulated by mechanical muscle damage, so it works synergistically with strength training stimulus.
  • Adequate protein intake
    Satellite cell proliferation and muscle repair driven by MGF requires sufficient amino acid substrate for actual tissue synthesis.
  • Growth hormone secretagogues (e.g., CJC-1295/Ipamorelin)
    GH elevates systemic IGF-1, which can complement MGF's localized muscle repair signaling.

⚠️ USE WITH CAUTION

  • Active or history of cancer
    Growth factor pathways that promote cell proliferation raise theoretical concern about stimulating malignant cell growth.
  • Diabetes/insulin sensitivity issues
    IGF-1 pathway peptides can affect glucose metabolism and insulin sensitivity, requiring monitoring in metabolic conditions.
  • Limited human clinical trial data
    PEG-MGF is primarily supported by animal and in vitro studies; long-term human safety and optimal dosing remain poorly established.

📋 IMPORTANT NOTES

  • ⏰ Optimal timing (consensus): Inject subcutaneously or intramuscularly post-workout, 2–3× weekly into the trained area or abdominal fat.
  • Swirl gently to dissolve. never shake; foaming can shear the peptide.
  • Rotate injection sites to avoid local irritation or bruising.
  • Do not stack with plain native MGF (redundant); avoid running IGF-1 LR3 simultaneously per community practice.
  • None of these peptides significantly lower blood glucose: no diabetic-interaction caution required.

⚗️ For research purposes only. Not for human consumption. This compound is not FDA-approved.